Search Results

You are looking at 1 - 10 of 22 items for :

  • biochemical markers of bone turnover x
Clear All
Open access

Martine Cohen-Solal, Thomas Funck-Brentano and Pablo Ureña Torres

evaluate early kidney disease. Kidney International 2006 71 31 – 38 . ( ) 28 Lehmann G Ott U Kaemmerer D Schuetze J Wolf G. Bone histomorphometry and biochemical markers of bone turnover in

Open access

Ann-Kristin Picke, Graeme Campbell, Nicola Napoli, Lorenz C Hofbauer and Martina Rauner

. World Journal of Diabetes 2014 5 14 – 16 . ( ) 24567798 10.4239/wjd.v5.i1.14 60 Starup-Linde J Vestergaard P. Biochemical bone turnover markers in diabetes mellitus – a systematic review . Bone 2016 82

Open access

Elena Valassi, Natalia García-Giralt, Jorge Malouf, Iris Crespo, Jaume Llauger, Adolfo Díez-Pérez and Susan M Webb

strength index (a marker of cortical bone properties), as assessed using microindentation, and femoral cortical volumetric bone mineral density (vBMD) have been described in ACRO patients despite biochemical control of the disease ( 8 , 9 ). miRNAs are

Open access

Stephen A Martin, Kenneth A Philbrick, Carmen P Wong, Dawn A Olson, Adam J Branscum, Donald B Jump, Charles K Marik, Jonathan M DenHerder, Jennifer L Sargent, Russell T Turner and Urszula T Iwaniec

measured using a glucometer (OneTouch Ultra Mini, LifeScan, Milpitas, CA, USA). Serum was collected and stored at −80°C for analyses of markers of bone turnover and leptin. Abdominal white adipose tissue (WAT) was removed and weighed. Right femora and the

Open access

Qianqian Pang, Yuping Xu, Xuan Qi, Yan Jiang, Ou Wang, Mei Li, Xiaoping Xing, Ling Qin and Weibo Xia

and bone turnover markers all decreased after treatment. The levels of the biochemical markers before and after treatment were shown in Table 1 . MRI of the bilateral knees showed remission of synovitis. Mutational analysis of HPGD Direct

Open access

Ulla Schmidt, Birte Nygaard, Ebbe Winther Jensen, Jan Kvetny, Anne Jarløv and Jens Faber

-known enhanced bone turnover in subclinical hyperthyroidism, both exogenous (due to T 4 treatment) and endogenous (21) . However, no difference was found in the PINP levels of patients on T 4 vs T 3 monotherapy (12) . It is not clear whether our findings are

Open access

Sylvia Thiele, Anke Hannemann, Maria Winzer, Ulrike Baschant, Heike Weidner, Matthias Nauck, Rajesh V Thakker, Martin Bornhäuser, Lorenz C Hofbauer and Martina Rauner

( Tables 1 and 2 ). Bone turnover markers in PMR patients were not affected as much as in patients with RA ( Tables 1 and 2 ). Thus, these results suggest that the intake of GCs leads to decreased sclerostin serum levels. Discussion

Open access

Stan Ursem, Vito Francic, Martin Keppel, Verena Schwetz, Christian Trummer, Marlene Pandis, Felix Aberer, Martin R Grübler, Nicolas D Verheyen, Winfried März, Andreas Tomaschitz, Stefan Pilz, Barbara Obermayer-Pietsch and Annemieke C Heijboer

n-oxPTH concentrations between groups, adjusted for baseline values. In addition, we studied the correlation between n-oxPTH, tPTH concentrations, markers of bone turnover, lipid metabolism, calcium and phosphate homeostasis and asymmetric

Open access

Malachi J McKenna and Barbara F Murray

. Zeitschrift für Rheumatologie 2003 62 518 – 521 . ( doi:10.1007/s00393-003-0561-4 ). 16 Bjorkman M Sorva A Risteli J Tilvis R . Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D

Open access

Gudmundur Johannsson, Martin Bidlingmaier, Beverly M K Biller, Margaret Boguszewski, Felipe F Casanueva, Philippe Chanson, Peter E Clayton, Catherine S Choong, David Clemmons, Mehul Dattani, Jan Frystyk, Ken Ho, Andrew R Hoffman, Reiko Horikawa, Anders Juul, John J Kopchick, Xiaoping Luo, Sebastian Neggers, Irene Netchine, Daniel S Olsson, Sally Radovick, Ron Rosenfeld, Richard J Ross, Katharina Schilbach, Paulo Solberg, Christian Strasburger, Peter Trainer, Kevin C J Yuen, Kerstin Wickstrom, Jens O L Jorgensen and on behalf of the Growth Hormone Research Society

Pentecost C , et al . Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study . Journal of Clinical Endocrinology and Metabolism 2000 85